A citation-based method for searching scientific literature

Roland E Schmieder, Johannes F E Mann, Helmut Schumacher, Peggy Gao, Giuseppe Mancia, Michael A Weber, Matthew McQueen, Teo Koon, Salim Yusuf. J Am Soc Nephrol 2011
Times Cited: 182







List of co-cited articles
1082 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial.
Johannes F E Mann, Roland E Schmieder, Matthew McQueen, Leanne Dyal, Helmut Schumacher, Janice Pogue, Xingyu Wang, Aldo Maggioni, Andrzej Budaj, Suphachai Chaithiraphan,[...]. Lancet 2008
17

Cardiorenal end points in a trial of aliskiren for type 2 diabetes.
Hans-Henrik Parving, Barry M Brenner, John J V McMurray, Dick de Zeeuw, Steven M Haffner, Scott D Solomon, Nish Chaturvedi, Frederik Persson, Akshay S Desai, Maria Nicolaides,[...]. N Engl J Med 2012
815
17

Drug-Induced Reduction in Albuminuria Is Associated with Subsequent Renoprotection: A Meta-Analysis.
Hiddo J Lambers Heerspink, Tobias F Kröpelin, Jarno Hoekman, Dick de Zeeuw. J Am Soc Nephrol 2015
158
17

Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals.
H C Gerstein, J F Mann, Q Yi, B Zinman, S F Dinneen, B Hoogwerf, J P Hallé, J Young, A Rashkow, C Joyce,[...]. JAMA 2001
17

A new equation to estimate glomerular filtration rate.
Andrew S Levey, Lesley A Stevens, Christopher H Schmid, Yaping Lucy Zhang, Alejandro F Castro, Harold I Feldman, John W Kusek, Paul Eggers, Frederick Van Lente, Tom Greene,[...]. Ann Intern Med 2009
16

Telmisartan, ramipril, or both in patients at high risk for vascular events.
Salim Yusuf, Koon K Teo, Janice Pogue, Leanne Dyal, Ingrid Copland, Helmut Schumacher, Gilles Dagenais, Peter Sleight, Craig Anderson. N Engl J Med 2008
16

Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes.
Toshiharu Ninomiya, Vlado Perkovic, Bastiaan E de Galan, Sophia Zoungas, Avinesh Pillai, Meg Jardine, Anushka Patel, Alan Cass, Bruce Neal, Neil Poulter,[...]. J Am Soc Nephrol 2009
625
16

Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis.
Kunihiro Matsushita, Marije van der Velde, Brad C Astor, Mark Woodward, Andrew S Levey, Paul E de Jong, Josef Coresh, Ron T Gansevoort. Lancet 2010
16

Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population.
Hans L Hillege, Vaclav Fidler, Gilles F H Diercks, Wiek H van Gilst, Dick de Zeeuw, Dirk J van Veldhuisen, Rijk O B Gans, Wilbert M T Janssen, Diederick E Grobbee, Paul E de Jong. Circulation 2002
13

Combined angiotensin inhibition for the treatment of diabetic nephropathy.
Linda F Fried, Nicholas Emanuele, Jane H Zhang, Mary Brophy, Todd A Conner, William Duckworth, David J Leehey, Peter A McCullough, Theresa O'Connor, Paul M Palevsky,[...]. N Engl J Med 2013
676
13

Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis.
Caroline S Fox, Kunihiro Matsushita, Mark Woodward, Henk J G Bilo, John Chalmers, Hiddo J Lambers Heerspink, Brian J Lee, Robert M Perkins, Peter Rossing, Toshimi Sairenchi,[...]. Lancet 2012
659
12

2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).
Giuseppe Mancia, Robert Fagard, Krzysztof Narkiewicz, Josep Redón, Alberto Zanchetti, Michael Böhm, Thierry Christiaens, Renata Cifkova, Guy De Backer, Anna Dominiczak,[...]. J Hypertens 2013
12

Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL.
Dick de Zeeuw, Giuseppe Remuzzi, Hans-Henrik Parving, William F Keane, Zhongxin Zhang, Shahnaz Shahinfar, Steve Snapinn, Mark E Cooper, William E Mitch, Barry M Brenner. Kidney Int 2004
716
12

2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).
Giuseppe Mancia, Robert Fagard, Krzysztof Narkiewicz, Josep Redon, Alberto Zanchetti, Michael Böhm, Thierry Christiaens, Renata Cifkova, Guy De Backer, Anna Dominiczak,[...]. Eur Heart J 2013
11

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy.
B M Brenner, M E Cooper, D de Zeeuw, W F Keane, W E Mitch, H H Parving, G Remuzzi, S M Snapinn, Z Zhang, S Shahinfar. N Engl J Med 2001
11

Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial.
George L Bakris, Pantelis A Sarafidis, Matthew R Weir, Björn Dahlöf, Bertram Pitt, Kenneth Jamerson, Eric J Velazquez, Linda Staikos-Byrne, Roxzana Y Kelly, Victor Shi,[...]. Lancet 2010
324
11

Relation between kidney function, proteinuria, and adverse outcomes.
Brenda R Hemmelgarn, Braden J Manns, Anita Lloyd, Matthew T James, Scott Klarenbach, Robert R Quinn, Natasha Wiebe, Marcello Tonelli. JAMA 2010
724
11

Albuminuria Is an Appropriate Therapeutic Target in Patients with CKD: The Pro View.
Hiddo J Lambers Heerspink, Ron T Gansevoort. Clin J Am Soc Nephrol 2015
94
11

Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
Bruce Neal, Vlado Perkovic, Kenneth W Mahaffey, Dick de Zeeuw, Greg Fulcher, Ngozi Erondu, Wayne Shaw, Gordon Law, Mehul Desai, David R Matthews. N Engl J Med 2017
11

Early change in proteinuria as a surrogate end point for kidney disease progression: an individual patient meta-analysis.
Lesley A Inker, Andrew S Levey, Kruti Pandya, Nicholas Stoycheff, Aghogho Okparavero, Tom Greene. Am J Kidney Dis 2014
80
12

Effects of intensive blood-pressure control in type 2 diabetes mellitus.
William C Cushman, Gregory W Evans, Robert P Byington, David C Goff, Richard H Grimm, Jeffrey A Cutler, Denise G Simons-Morton, Jan N Basile, Marshall A Corson, Jeffrey L Probstfield,[...]. N Engl J Med 2010
10

Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention.
Ron T Gansevoort, Ricardo Correa-Rotter, Brenda R Hemmelgarn, Tazeen H Jafar, Hiddo J Lambers Heerspink, Johannes F Mann, Kunihiro Matsushita, Chi Pang Wen. Lancet 2013
10

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
Bernard Zinman, Christoph Wanner, John M Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd Erik Johansen, Hans J Woerle,[...]. N Engl J Med 2015
10

Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy.
Dick de Zeeuw, Giuseppe Remuzzi, Hans-Henrik Parving, William F Keane, Zhongxin Zhang, Shahnaz Shahinfar, Steve Snapinn, Mark E Cooper, William E Mitch, Barry M Brenner. Circulation 2004
571
9

2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8).
Paul A James, Suzanne Oparil, Barry L Carter, William C Cushman, Cheryl Dennison-Himmelfarb, Joel Handler, Daniel T Lackland, Michael L LeFevre, Thomas D MacKenzie, Olugbenga Ogedegbe,[...]. JAMA 2014
9

Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients: losartan intervention for endpoint reduction in hypertension study.
Hans Ibsen, Michael H Olsen, Kristian Wachtell, Knut Borch-Johnsen, Lars H Lindholm, Carl Erik Mogensen, Björn Dahlöf, Richard B Devereux, Ulf de Faire, Frej Fyhrquist,[...]. Hypertension 2005
416
9

Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes.
Hermann Haller, Sadayoshi Ito, Joseph L Izzo, Andrzej Januszewicz, Shigehiro Katayama, Jan Menne, Albert Mimran, Ton J Rabelink, Eberhard Ritz, Luis M Ruilope,[...]. N Engl J Med 2011
545
9

Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes.
Christoph Wanner, Silvio E Inzucchi, John M Lachin, David Fitchett, Maximilian von Eynatten, Michaela Mattheus, Odd Erik Johansen, Hans J Woerle, Uli C Broedl, Bernard Zinman. N Engl J Med 2016
9

A Randomized Trial of Intensive versus Standard Blood-Pressure Control.
Jackson T Wright, Jeff D Williamson, Paul K Whelton, Joni K Snyder, Kaycee M Sink, Michael V Rocco, David M Reboussin, Mahboob Rahman, Suzanne Oparil, Cora E Lewis,[...]. N Engl J Med 2015
9

Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study.
Johan Arnlöv, Jane C Evans, James B Meigs, Thomas J Wang, Caroline S Fox, Daniel Levy, Emelia J Benjamin, Ralph B D'Agostino, Ramachandran S Vasan. Circulation 2005
567
8



Albuminuria reflects widespread vascular damage. The Steno hypothesis.
T Deckert, B Feldt-Rasmussen, K Borch-Johnsen, T Jensen, A Kofoed-Enevoldsen. Diabetologia 1989
8

Albuminuria changes are associated with subsequent risk of end-stage renal disease and mortality.
Juan Jesús Carrero, Morgan E Grams, Yingying Sang, Johan Ärnlöv, Alessandro Gasparini, Kunihiro Matsushita, Abdul R Qureshi, Marie Evans, Peter Barany, Bengt Lindholm,[...]. Kidney Int 2017
70
11

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
Steven P Marso, Gilbert H Daniels, Kirstine Brown-Frandsen, Peter Kristensen, Johannes F E Mann, Michael A Nauck, Steven E Nissen, Stuart Pocock, Neil R Poulter, Lasse S Ravn,[...]. N Engl J Med 2016
8

Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
Steven P Marso, Stephen C Bain, Agostino Consoli, Freddy G Eliaschewitz, Esteban Jódar, Lawrence A Leiter, Ildiko Lingvay, Julio Rosenstock, Jochen Seufert, Mark L Warren,[...]. N Engl J Med 2016
8

Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64).
Amanda I Adler, Richard J Stevens, Sue E Manley, Rudy W Bilous, Carole A Cull, Rury R Holman. Kidney Int 2003
7

Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis.
Bakhtawar K Mahmoodi, Kunihiro Matsushita, Mark Woodward, Peter J Blankestijn, Massimo Cirillo, Takayoshi Ohkubo, Peter Rossing, Mark J Sarnak, Bénédicte Stengel, Kazumasa Yamagishi,[...]. Lancet 2012
293
7

Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts.
Ron T Gansevoort, Kunihiro Matsushita, Marije van der Velde, Brad C Astor, Mark Woodward, Andrew S Levey, Paul E de Jong, Josef Coresh. Kidney Int 2011
506
7

Proteinuria reduction and progression to renal failure in patients with type 2 diabetes mellitus and overt nephropathy.
Robert C Atkins, Esther M Briganti, Julia B Lewis, Lawrence G Hunsicker, Gregory Braden, Paul J Champion de Crespigny, Giacomo DeFerrari, Paul Drury, Francesco Locatelli, Thomas B Wiegmann,[...]. Am J Kidney Dis 2005
250
7

Diabetic kidney disease: a report from an ADA Consensus Conference.
Katherine R Tuttle, George L Bakris, Rudolf W Bilous, Jane L Chiang, Ian H de Boer, Jordi Goldstein-Fuchs, Irl B Hirsch, Kamyar Kalantar-Zadeh, Andrew S Narva, Sankar D Navaneethan,[...]. Diabetes Care 2014
521
7

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization.
Alan S Go, Glenn M Chertow, Dongjie Fan, Charles E McCulloch, Chi-yuan Hsu. N Engl J Med 2004
7


Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes.
E J Lewis, L G Hunsicker, W R Clarke, T Berl, M A Pohl, J B Lewis, E Ritz, R C Atkins, R Rohde, I Raz. N Engl J Med 2001
7

Reduction of albumin urinary excretion is associated with reduced cardiovascular events in hypertensive and/or diabetic patients. A meta-regression analysis of 32 randomized trials.
Gianluigi Savarese, Alessandra Dei Cas, Giuseppe Rosano, Carmen D'Amore, Francesca Musella, Susanna Mosca, Martin F Reiner, Roberto Marchioli, Bruno Trimarco, Pasquale Perrone-Filardi. Int J Cardiol 2014
29
24

Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts.
Brad C Astor, Kunihiro Matsushita, Ron T Gansevoort, Marije van der Velde, Mark Woodward, Andrew S Levey, Paul E de Jong, Josef Coresh, Brad C Astor, Kunihiro Matsushita,[...]. Kidney Int 2011
473
7

Liraglutide and Renal Outcomes in Type 2 Diabetes.
Johannes F E Mann, David D Ørsted, Kirstine Brown-Frandsen, Steven P Marso, Neil R Poulter, Søren Rasmussen, Karen Tornøe, Bernard Zinman, John B Buse. N Engl J Med 2017
573
7

Changes in Albuminuria and the Risk of Major Clinical Outcomes in Diabetes: Results From ADVANCE-ON.
Min Jun, Toshiaki Ohkuma, Sophia Zoungas, Stephen Colagiuri, Giuseppe Mancia, Michel Marre, David Matthews, Neil Poulter, Bryan Williams, Anthony Rodgers,[...]. Diabetes Care 2018
30
23

GFR decline as an end point for clinical trials in CKD: a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration.
Andrew S Levey, Lesley A Inker, Kunihiro Matsushita, Tom Greene, Kerry Willis, Edmund Lewis, Dick de Zeeuw, Alfred K Cheung, Josef Coresh. Am J Kidney Dis 2014
326
6

Proteinuria as a surrogate outcome in CKD: report of a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration.
Andrew S Levey, Daniel Cattran, Aaron Friedman, W Greg Miller, John Sedor, Katherine Tuttle, Bertram Kasiske, Thomas Hostetter. Am J Kidney Dis 2009
225
6


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.